分组1 - ICU Medical reported quarterly earnings of $2.03 per share, exceeding the Zacks Consensus Estimate of $1.54 per share, and showing an increase from $1.59 per share a year ago, resulting in an earnings surprise of +31.82% [1] - The company achieved revenues of $533.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.66%, although this represents a decline from year-ago revenues of $580.07 million [2] - Over the last four quarters, ICU Medical has consistently surpassed consensus EPS and revenue estimates [2] 分组2 - The stock has underperformed, losing about 17.9% since the beginning of the year, compared to the S&P 500's gain of 15.6% [3] - The current consensus EPS estimate for the upcoming quarter is $1.66 on revenues of $527.85 million, and for the current fiscal year, it is $7.03 on revenues of $2.19 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 40% of over 250 Zacks industries, which may negatively impact stock performance [8]
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates